Noninvasive Ventilation Masks Market is expected to reach US$ 3.25 Billion by 2031

Noninvasive Ventilation Disposable Mask Segment to Bolster Noninvasive Ventilation Masks Market Growth During 2023–2031

According to our new research study on "Noninvasive Ventilation Masks Market Forecast to 2031 – Global Analysis – by Product, Application, and End User," the market is expected to grow from US$ 2.05 billion in 2023 to US$ 3.25 billion by 2031; it is anticipated to record a CAGR of 5.9% from 2023 to 2031. The noninvasive ventilation masks market report emphasizes the trends prevalent in the global market, along with drivers and deterrents affecting its growth.

The increasing prevalence of respiratory ailments and the rising shift toward home healthcare are contributing to the noninvasive ventilation masks market growth. However, side effects associated with NIV masks hamper the market growth. Nevertheless, technological advancements in noninvasive ventilation masks are expected to bring new noninvasive ventilation masks market trends in the coming years.

Noninvasive Ventilation Masks Market Share, by Region, 2023 (%)

Source: The Insight Partners Analysis

Growing Prevalence of Respiratory Ailments Bolsters Noninvasive Ventilation Masks Market  

The prevalence of respiratory illnesses such as asthma, obstructive sleep apnea (OSA), and chronic obstructive pulmonary disease (COPD) is rising worldwide. According to the Centers for Disease Control and Prevention (CDC), in 2022, 11.7 million people were diagnosed with COPD, chronic bronchitis, or emphysema. COPD causes persistent and progressive respiratory symptoms that include breathing difficulty, cough, and phlegm production. NIV provides adequate ventilation support in COPD patients. The NIV masks improve gas exchange and reduce inspiratory effort. In COPD patients, the mask is the first choice of interface when NIV is applied for prolonged periods. ResMed, Philips, and Sleepnet Corporation are among the market players offering NIV masks to treat COPD.

Similarly, Dräger, Fisher & Paykel Healthcare, and ResMed offer NIV masks designed for treating OSA. Moreover, Fisher & Paykel Healthcare's masks are designed with advanced features such as an innovative AirPillow seal, Adjustable headgear, Washable Diffuser, and VisiBlue for enhancing comfort.

NIV therapy is also helpful for treating pneumonia—a lung infection that inflames the air sacs in one or both lungs. The risk factors that make a person immunocompromised for pneumonia include chronic lung diseases such as COPD, bronchiectasis, dementia and other brain disorders, and heart disease. Pneumonia can range from mild to life-threatening conditions. It is most serious in infants, young children, the population aged 65 years and above, and immunodeficients. The most commonly used NIV modalities for treating community-acquired pneumonia are continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP). In pneumonia patients, NIV therapy improves oxygenation and, for those who respond, may reduce the need for invasive mechanical ventilation (IMV), eventually helping in reducing the mortality rates.

The noninvasive ventilation masks market analysis has been carried out by considering the following segments: product, application, end user, and geography. Based on product, the noninvasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held a larger share of the noninvasive ventilation masks market in 2023. Disposable noninvasive ventilation masks are single-use masks and are disposed off to reduce the risk of cross-contamination. These masks are used to maintain or improve arterial oxygenation to manage hypoxemia in high-risk patients. For instance, the Janus ventilation mask by Biomedical SRL is a full-face mask that provides oxygen during sedation without tracheal intubation. It features an airtight port for transesophageal echocardiography inspection and allows for NIV in cases of acute respiratory failure. The mask can be opened and removed without disturbing the instrument if needed. Therefore, the rising requirement for high-quality disposable solutions from patients who need NIV therapy propels the demand for single-use/disposable NIV masks. Market players such as Hamilton Medical, Philips, and Intersurgical offer a wide range of single-use NIV masks for both pediatric and adult patients. Hamilton’s Pulmodyne BiTrac masks have adjustable headgear and easy-to-use clips and are tailored as one-size-fits-all.

Based on application, the noninvasive ventilation masks market is segmented into obstructive sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held the largest share in the noninvasive ventilation masks market in 2023. OSA is a chronic condition characterized by repeated upper airway obstruction during sleep, often leading to sudden arousals with or without oxygen desaturation. Typical symptoms include excessive daytime sleepiness, morning headaches, poor concentration, fatigue, nocturia, and disrupted sleep. Untreated OSA results in higher mortality and larger comorbidities, such as hypertension, stroke, heart failure, diabetes, and depression. The National Council on Aging (NCOA) estimated that in 2023, 30 million Americans suffered from sleep apnea, with older adults being at higher risk. ~56% of the elderly population (aged 65 and above) are at higher risk, out of which only ~20% have been diagnosed with the disease. OSA is often associated with hypercapnic chronic respiratory failure (CRF) in conditions such as obesity (particularly in overlap syndrome), COPD, neuromuscular diseases, and restrictive lung diseases. OSA can lead to hypoventilation and has a synergistic harmful effect. NIV is an effective treatment for patients with severe OSA associated with obesity hypoventilation syndrome (OHS).

Based on end user, the noninvasive ventilation masks market is segmented into hospitals and clinics, homecare, and others. The hospitals and clinics segment held the largest share in the noninvasive ventilation masks market in 2023. There has been an increase in medical costs over the last few decades with developments in healthcare technology. Development in hospital technologies, reforms in health insurance policies, economic growth of various regions, improved reimbursement programs, and various products and services provided are among the major reasons fueling the noninvasive ventilation masks market growth for the hospital and clinics segment. The growing number of hospitalizations due to increasing incidences of diseases such as asthma, COPD, and other chronic respiratory disorders, and the worldwide presence of hospitals such as Harefield Hospital, SingHealth Group of hospitals, and the Royal Gwent Hospital that provide NIV services also drive the market growth for the segment. The Royal Gwent Hospital, Newport, UK, has been providing NIV retrieval services (NRS) since 2017 with the aim of facilitating optimal management of patients requiring NIV therapy.

The geographic scope of the noninvasive ventilation masks market report includes the assessment of the market performance in North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), the South & Central America (Brazil, Argentina, and Rest of South & Central America), and the Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa). North America dominated the noninvasive ventilation masks market in 2023. The US holds the largest noninvasive ventilation masks market size. Europe is the second-largest contributor to the global noninvasive ventilation masks market, followed by Asia Pacific.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com